Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
Clinical trial NCT00600509 · COMPLETED
Trial details
- NCT number
- NCT00600509
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2003-07-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.